Targeting sphingosine-1-phosphate receptors in cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 9, 2011, Pages 810-817

  Watters, Rebecca J ^a   Wang, Hong Gang ^a   Sung, Shen Shu ^a   Loughran Jr , Thomas P ^a   Liu, Xin ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

G protein coupled receptors (GPCR); Leukemia; Sphingosine 1 phosphate (S1P); Sphingosine 1 phosphate receptors (S1PR)

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; 2 AMINO 2 [2 [4 (3 BENZYLOXYPHENYLTHIO) 2 CHLOROPHENYL]ETHYL] 1,3 PROPANEDIOL; 3 AMINO 4 (3 HEXYLPHENYLAMINO) 4 OXOBUTYLPHOSPHONIC ACID; 3 [[(3 HEXYLPHENYLCARBAMOYL)METHYL]AMINO]PROPIONIC ACID; 4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; ANTINEOPLASTIC AGENT; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; LT 1009; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; SPHINGOSINE 1 PHOSPHATE RECEPTOR 4; SPHINGOSINE 1 PHOSPHATE RECEPTOR 5; SURAMIN; UNCLASSIFIED DRUG; W 123; W 146;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; B CELL LYMPHOMA; BLADDER CANCER; BRADYCARDIA; BREAST CANCER; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOTAXIS; CHRONIC LYMPHATIC LEUKEMIA; DRUG MECHANISM; DRUG TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; LIPID METABOLISM; LIVER CELL CARCINOMA; LYMPHOBLASTOMA; LYMPHOCYTOPENIA; NONHUMAN; PROSTATE CANCER; PROTEIN FAMILY; REGULATORY MECHANISM; RETINA MACULA EDEMA; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

EID: 80054077522     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011797655041     Document Type: Review

References (91)

1. Lappano, R.; Maggiolini, M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov., 2011, 10(1), 47-60.
2. Dorsam, R. T.; Gutkind, J. S. G-protein-coupled receptors and cancer. Nat. Rev. Cancer. 2007, 7(2), 79-94.
3. Neves, S. R.; Ram, P. T.; Iyengar, R. G protein pathways. Science. 2002, 296(5573), 1636-1639.
4. Siehler, S.; Manning, D. R. Pathways of transduction engaged by sphingosine 1-phosphate through G protein-coupled receptors. Biochim. Biophys. Acta. 2002, 1582(1-3), 94-99.
5. Waller, A.; Simons, P. C.; Biggs, S. M.; Edwards, B. S.; Prossnitz, E. R.; Sklar, L. A. Techniques: GPCR assembly, pharmacology and screening by flow cytometry. Trends Pharmacol. Sci., 2004, 25(12), 663-669.
6. Chung, S.; Funakoshi, T.; Civelli, O. Orphan GPCR research. Br. J. Pharmacol., 2008, 153 Suppl 1, S339-346.
7. Overington, J. P.; Al-Lazikani, B.; Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug Discov., 2006, 5(12), 993-996.
8. Young, D.; Waitches, G.; Birchmeier, C.; Fasano, O.; Wigler, M. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell. 1986, 45(5), 711-719.
9. Cotton, M.; Claing, A. G protein-coupled receptors stimulation and the control of cell migration. Cell. Signal., 2009, 21(7), 1045-1053.
10. Raman, D.; Baugher, P. J.; Thu, Y. M.; Richmond, A. Role of chemokines in tumor growth. Cancer Lett., 2007, 256(2), 137-165.
11. Phillips, R. J.; Mestas, J.; Gharaee-Kermani, M.; Burdick, M. D.; Sica, A.; Belperio, J. A.; Keane, M. P.; Strieter, R. M. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J. Biol. Chem., 2005, 280(23), 22473-22481.
12. Radeff-Huang, J.; Seasholtz, T. M.; Matteo, R. G.; Brown, J. H. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival. J. Cell. Biochem., 2004, 92(5), 949-966.
13. Wang, K.; Wong, Y. H. G protein signaling controls the differentiation of multiple cell lineages. Biofactors. 2009, 35(3), 232-238.
14. Chen, X.; Zhu, H.; Yuan, M.; Fu, J.; Zhou, Y.; Ma, L. G-proteincoupled receptor kinase 5 phosphorylates p53 and inhibits DNA damage-induced apoptosis. J. Biol. Chem., 2010, 285(17), 12823-12830.
15. Hla, T.; Lee, M. J.; Ancellin, N.; Paik, J. H.; Kluk, M. J. Lysophospholipids--receptor revelations. Science. 2001, 294(5548), 1875-1878.
16. Kothapalli, R.; Kusmartseva, I.; Loughran, T. P. Characterization of a human sphingosine-1-phosphate receptor gene (S1P5) and its differential expression in LGL leukemia. Biochim. Biophys. Acta, 2002, 1579(2-3), 117-123.
17. Spiegel, S.; Cuvillier, O.; Edsall, L. C.; Kohama, T.; Menzeleev, R.; Olah, Z.; Olivera, A.; Pirianov, G.; Thomas, D. M.; Tu, Z.; Van Brocklyn, J. R.; Wang, F. Sphingosine-1-phosphate in cell growth and cell death. Ann. N. Y. Acad. Sci., 1998, 845, 11-18.
18. Jeffery, D. R.; Markowitz, C. E.; Reder, A. T.; Weinstock- Guttman, B.; Tobias, K. Fingolimod for the treatment of relapsing multiple sclerosis. Expert Rev. Neurother., 2011, 11(2), 165-183.
19. Pyne, N. J.; Pyne, S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer. 2010, 10(7), 489-503.
20. Walzer, T.; Jaeger, S.; Chaix, J.; Vivier, E. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr. Opin. Immunol., 2007, 19(3), 365-372.
21. Yamazaki, Y.; Kon, J.; Sato, K.; Tomura, H.; Sato, M.; Yoneya, T.; Okazaki, H.; Okajima, F.; Ohta, H. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway. Biochem. Biophys. Res. Commun., 2000, 268(2), 583-589.
22. Malek, R. L.; Toman, R. E.; Edsall, L. C.; Wong, S.; Chiu, J.; Letterle, C. A.; Van Brocklyn, J. R.; Milstien, S.; Spiegel, S.; Lee, N. H. Nrg-1 belongs to the endothelial differentiation gene family of G protein-coupled sphingosine-1-phosphate receptors. J. Biol. Chem., 2001, 276(8), 5692-5699.
23. Im, D. S.; Heise, C. E.; Ancellin, N.; O'Dowd, B. F.; Shei, G. J.; Heavens, R. P.; Rigby, M. R.; Hla, T.; Mandala, S.; McAllister, G.; George, S. R.; Lynch, K. R. Characterization of a novel sphingosine 1-phosphate receptor, Edg-8. J. Biol. Chem., 2000, 275(19), 14281-14286.
24. Van Brocklyn, J. R.; Graler, M. H.; Bernhardt, G.; Hobson, J. P.; Lipp, M.; Spiegel, S. Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood. 2000, 95(8), 2624-2629.
25. Kumar, R.; Gururaj, A. E.; Barnes, C. J. p21-activated kinases in cancer. Nat. Rev. Cancer. 2006, 6(6), 459-471.
26. Vega, F. M.; Ridley, A. J. Rho GTPases in cancer cell biology. FEBS Lett., 2008, 582(14), 2093-2101.
27. Gomez del Pulgar, T.; Benitah, S. A.; Valeron, P. F.; Espina, C.; Lacal, J. C. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays. 2005, 27(6), 602-613.
28. Canguilhem, B.; Pradines, A.; Baudouin, C.; Boby, C.; Lajoie- Mazenc, I.; Charveron, M.; Favre, G. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. J. Biol. Chem., 2005, 280(52), 43257-43263.
29. Cuvillier, O.; Pirianov, G.; Kleuser, B.; Vanek, P. G.; Coso, O. A.; Gutkind, S.; Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 1996, 381(6585), 800-803.
30. Rosen, H.; Gonzalez-Cabrera, P. J.; Sanna, M. G.; Brown, S. Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem., 2009, 78, 743-768.
31. Chi, H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol. Sci., 2011, 32(1), 16-24.
32. Pitson, S. M.; Moretti, P. A.; Zebol, J. R.; Lynn, H. E.; Xia, P.; Vadas, M. A.; Wattenberg, B. W. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J., 2003, 22(20), 5491-5500.
33. Ding, G.; Sonoda, H.; Yu, H.; Kajimoto, T.; Goparaju, S. K.; Jahangeer, S.; Okada, T.; Nakamura, S. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem., 2007, 282(37), 27493-27502.
34. Hanel, P.; Andreani, P.; Graler, M. H. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J., 2007, 21(4), 1202-1209.
35. Li, Q. F.; Wu, C. T.; Guo, Q.; Wang, H.; Wang, L. S. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis. Biochem. Biophys. Res. Commun., 2008, 371(1), 159-162.
36. Baran, Y.; Salas, A.; Senkal, C. E.; Gunduz, U.; Bielawski, J.; Obeid, L. M.; Ogretmen, B. Alterations of ceramide/sphingosine 1- phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J. Biol. Chem., 2007, 282(15), 10922-10934.
37. Takabe, K.; Paugh, S. W.; Milstien, S.; Spiegel, S. Inside-out signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev., 2008, 60(2), 181-195.
38. Seitz, G.; Boehmler, A. M.; Kanz, L.; Mohle, R. The role of sphingosine 1-phosphate receptors in the trafficking of hematopoietic progenitor cells. Ann. N. Y. Acad. Sci., 2005, 1044, 84-89.
39. Yanai, N.; Matsui, N.; Furusawa, T.; Okubo, T.; Obinata, M. Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers. Blood. 2000, 96(1), 139-144.
40. O'Brien, N.; Jones, S. T.; Williams, D. G.; Cunningham, H. B.; Moreno, K.; Visentin, B.; Gentile, A.; Vekich, J.; Shestowsky, W.; Hiraiwa, M.; Matteo, R.; Cavalli, A.; Grotjahn, D.; Grant, M.; Hansen, G.; Campbell, M. A.; Sabbadini, R. Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies. J. Lipid Res., 2009, 50(11), 2245-2257.
41. Ancellin, N.; Hla, T. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J. Biol. Chem., 1999, 274(27), 18997-19002.
42. Jo, S. K.; Bajwa, A.; Awad, A. S.; Lynch, K. R.; Okusa, M. D. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int., 2008, 73(11), 1220-1230.
43. Feng, H.; Stachura, D. L.; White, R. M.; Gutierrez, A.; Zhang, L.; Sanda, T.; Jette, C. A.; Testa, J. R.; Neuberg, D. S.; Langenau, D. M.; Kutok, J. L.; Zon, L. I.; Traver, D.; Fleming, M. D.; Kanki, J. P.; Look, A. T. T-lymphoblastic lymphoma cells express high levels of BCL2, S1P1, and ICAM1, leading to a blockade of tumor cell intravasation. Cancer Cell. 2010, 18(4), 353-366.
44. Waters, C. M.; Long, J.; Gorshkova, I.; Fujiwara, Y.; Connell, M.; Belmonte, K. E.; Tigyi, G.; Natarajan, V.; Pyne, S.; Pyne, N. J. Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. FASEB J., 2006, 20(3), 509-511.
45. Dorsam, G.; Graeler, M. H.; Seroogy, C.; Kong, Y.; Voice, J. K.; Goetzl, E. J. Transduction of multiple effects of sphingosine 1- phosphate (S1P) on T cell functions by the S1P1 G protein-coupled receptor. J. Immunol., 2003, 171(7), 3500-3507.
46. Yoshida, Y.; Nakada, M.; Harada, T.; Tanaka, S.; Furuta, T.; Hayashi, Y.; Kita, D.; Uchiyama, N.; Hamada, J. The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB- 1 labeling index and predicts survival of glioblastoma patients. J. Neurooncol., 2010, 98(1), 41-47.
47. Liu, Y.; Wada, R.; Yamashita, T.; Mi, Y.; Deng, C. X.; Hobson, J. P.; Rosenfeldt, H. M.; Nava, V. E.; Chae, S. S.; Lee, M. J.; Liu, C. H.; Hla, T.; Spiegel, S.; Proia, R. L. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest., 2000, 106(8), 951-961.
48. Choi, J. W.; Lee, C. W.; Chun, J. Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. Biochim. Biophys. Acta. 2008, 1781(9), 531-539.
49. Cattoretti, G.; Mandelbaum, J.; Lee, N.; Chaves, A. H.; Mahler, A. M.; Chadburn, A.; Dalla-Favera, R.; Pasqualucci, L.; MacLennan, A. J. Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res., 2009, 69(22), 8686-8692.
50. Kluk, M. J.; Hla, T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta, 2002, 1582(1-3), 72-80.
51. Du, W.; Takuwa, N.; Yoshioka, K.; Okamoto, Y.; Gonda, K.; Sugihara, K.; Fukamizu, A.; Asano, M.; Takuwa, Y. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res., 2010, 70(2), 772-781.
52. Ishii, I.; Friedman, B.; Ye, X.; Kawamura, S.; McGiffert, C.; Contos, J. J.; Kingsbury, M. A.; Zhang, G.; Brown, J. H.; Chun, J. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G proteincoupled receptor, LP(B3)/EDG-3. J. Biol. Chem., 2001, 276(36), 33697-33704.
53. Goparaju, S. K.; Jolly, P. S.; Watterson, K. R.; Bektas, M.; Alvarez, S.; Sarkar, S.; Mel, L.; Ishii, I.; Chun, J.; Milstien, S.; Spiegel, S. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol., 2005, 25(10), 4237-4249.
54. Arikawa, K.; Takuwa, N.; Yamaguchi, H.; Sugimoto, N.; Kitayama, J.; Nagawa, H.; Takehara, K.; Takuwa, Y. Liganddependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem., 2003, 278(35), 32841-32851.
55. Van Brocklyn, J. R.; Jackson, C. A.; Pearl, D. K.; Kotur, M. S.; Snyder, P. J.; Prior, T. W. Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol., 2005, 64(8), 695-705.
56. Li, M. H.; Sanchez, T.; Milne, G. L.; Morrow, J. D.; Hla, T.; Ferrer, F. S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor. J. Urol., 2009, 181(3), 1347-1352.
57. Magrassi, L.; Marziliano, N.; Inzani, F.; Cassini, P.; Chiaranda, I.; Skrap, M.; Pizzolito, S.; Arienta, C.; Arbustini, E. EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas. Cancer Lett., 2010, 290(1), 36-42.
58. Dolezalova, H.; Shankar, G.; Huang, M. C.; Bikle, D. D.; Goetzl, E. J. Biochemical regulation of breast cancer cell expression of S1P2 (Edg-5) and S1P3 (Edg-3) G protein-coupled receptors for sphingosine 1-phosphate. J. Cell. Biochem., 2003, 88(4), 732-743.
59. Graler, M. H.; Grosse, R.; Kusch, A.; Kremmer, E.; Gudermann, T.; Lipp, M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J. Cell. Biochem., 2003, 89(3), 507-519.
60. Golfier, S.; Kondo, S.; Schulze, T.; Takeuchi, T.; Vassileva, G.; Achtman, A. H.; Graler, M. H.; Abbondanzo, S. J.; Wiekowski, M.; Kremmer, E.; Endo, Y.; Lira, S. A.; Bacon, K. B.; Lipp, M. Shaping of terminal megakaryocyte differentiation and proplatelet development by sphingosine-1-phosphate receptor S1P4. FASEB J., 2010, 24(12), 4701-4710.
61. Long, J. S.; Fujiwara, Y.; Edwards, J.; Tannahill, C. L.; Tigyi, G.; Pyne, S.; Pyne, N. J. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase- 1/2 in MDA-MB-453 breast cancer cells. J. Biol. Chem., 2010, 285(46), 35957-35966.
62. Shah, M. V.; Zhang, R.; Irby, R.; Kothapalli, R.; Liu, X.; Arrington, T.; Frank, B.; Lee, N. H.; Loughran, T. P., Jr. Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood. 2008, 112(3), 770-781.
63. Niedernberg, A.; Blaukat, A.; Schoneberg, T.; Kostenis, E. Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor. Br. J. Pharmacol., 2003, 138(3), 481-493.
64. Niedernberg, A.; Scherer, C. R.; Busch, A. E.; Kostenis, E. Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists. Biochem. Pharmacol., 2002, 64(8), 1243-1250.
65. Jaillard, C.; Harrison, S.; Stankoff, B.; Aigrot, M. S.; Calver, A. R.; Duddy, G.; Walsh, F. S.; Pangalos, M. N.; Arimura, N.; Kaibuchi, K.; Zalc, B.; Lubetzki, C. Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J. Neurosci., 2005, 25(6), 1459-1469.
66. Chang, C. L.; Ho, M. C.; Lee, P. H.; Hsu, C. Y.; Huang, W. P.; Lee, H. S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells. Am. J. Physiol. Cell Physiol., 2009, 297(2), C451-458.
67. Walzer, T.; Chiossone, L.; Chaix, J.; Calver, A.; Carozzo, C.; Garrigue-Antar, L.; Jacques, Y.; Baratin, M.; Tomasello, E.; Vivier, E. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol., 2007, 8(12), 1337-1344.
68. Novgorodov, A. S.; El-Alwani, M.; Bielawski, J.; Obeid, L. M.; Gudz, T. I. Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J., 2007, 21(7), 1503-1514.
69. Brinkmann, V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther. 2007, 115(1), 84-105.
70. Kappos, L.; Radue, E. W.; O'Connor, P.; Polman, C.; Hohlfeld, R.; Calabresi, P.; Selmaj, K.; Agoropoulou, C.; Leyk, M.; Zhang- Auberson, L.; Burtin, P. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med., 2010, 362(5), 387-401.
71. Cohen, J. A.; Barkhof, F.; Comi, G.; Hartung, H. P.; Khatri, B. O.; Montalban, X.; Pelletier, J.; Capra, R.; Gallo, P.; Izquierdo, G.; Tiel-Wilck, K.; de Vera, A.; Jin, J.; Stites, T.; Wu, S.; Aradhye, S.; Kappos, L. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med., 2010, 362(5), 402-415.
72. Chun, J.; Hartung, H. P. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin. Neuropharmacol., 2010, 33(2), 91-101.
73. Mehling, M.; Lindberg, R.; Raulf, F.; Kuhle, J.; Hess, C.; Kappos, L.; Brinkmann, V. Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis. Neurology. 2010, 75(5), 403-410.
74. Hofmann, M.; Brinkmann, V.; Zerwes, H. G. FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs. Int. Immunopharmacol., 2006, 6(13-14), 1902-1910.
75. Zhang, N.; Qi, Y.; Wadham, C.; Wang, L.; Warren, A.; Di, W.; Xia, P. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy. 2010, 6(8), 1157-1167.
76. Hung, J. H.; Lu, Y. S.; Wang, Y. C.; Ma, Y. H.; Wang, D. S.; Kulp, S. K.; Muthusamy, N.; Byrd, J. C.; Cheng, A. L.; Chen, C. S. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res., 2008, 68(4), 1204-1212.
77. Neviani, P.; Santhanam, R.; Oaks, J. J.; Eiring, A. M.; Notari, M.; Blaser, B. W.; Liu, S.; Trotta, R.; Muthusamy, N.; Gambacorti- Passerini, C.; Druker, B. J.; Cortes, J.; Marcucci, G.; Chen, C. S.; Verrills, N. M.; Roy, D. C.; Caligiuri, M. A.; Bloomfield, C. D.; Byrd, J. C.; Perrotti, D. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin. Invest., 2007, 117(9), 2408-2421.
78. Lee, W. J.; Yoo, H. S.; Suh, P. G.; Oh, S.; Lim, J. S.; Lee, Y. M. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. Exp. Mol. Med., 2004, 36(5), 420-427.
79. Hung, W. C.; Chang, H. C.; Chuang, L. Y. Activation of caspase-3- like proteases in apoptosis induced by sphingosine and other longchain bases in Hep3B hepatoma cells. Biochem. J., 1999, 338 (Pt 1), 161-166.
80. Shimizu, H.; Takahashi, M.; Kaneko, T.; Murakami, T.; Hakamata, Y.; Kudou, S.; Kishi, T.; Fukuchi, K.; Iwanami, S.; Kuriyama, K.; Yasue, T.; Enosawa, S.; Matsumoto, K.; Takeyoshi, I.; Morishita, Y.; Kobayashi, E. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation. 2005, 111(2), 222-229.
81. Huwiler, A.; Pfeilschifter, J. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets. Biochem. Pharmacol., 2008, 75(10), 1893-1900.
82. Jo, E.; Sanna, M. G.; Gonzalez-Cabrera, P. J.; Thangada, S.; Tigyi, G.; Osborne, D. A.; Hla, T.; Parrill, A. L.; Rosen, H. S1P1- selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol., 2005, 12(6), 703-715.
83. Sumida, G. M.; Stamer, W. D. S1P2 receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology. Am. J. Physiol. Cell Physiol., 2011.
84. Osada, M.; Yatomi, Y.; Ohmori, T.; Ikeda, H.; Ozaki, Y. Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem. Biophys. Res. Commun., 2002, 299(3), 483-487.
85. Young, N.; Van Brocklyn, J. R. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness. Exp. Cell Res., 2007, 313(8), 1615-1627.
86. Kawanabe, T.; Kawakami, T.; Yatomi, Y.; Shimada, S.; Soma, Y. Sphingosine 1-phosphate accelerates wound healing in diabetic mice. J. Dermatol. Sci., 2007, 48(1), 53-60.
87. Voogd, T. E.; Vansterkenburg, E. L.; Wilting, J.; Janssen, L. H. Recent research on the biological activity of suramin. Pharmacol. Rev., 1993, 45(2), 177-203.
88. Li, C.; Jiang, X.; Yang, L.; Liu, X.; Yue, S.; Li, L. Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasisinduced liver fibrosis. Am. J. Pathol., 2009, 175(4), 1464-1472.
89. Davis, M. D.; Clemens, J. J.; Macdonald, T. L.; Lynch, K. R. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem., 2005, 280(11), 9833-9841.
90. Wei, S. H.; Rosen, H.; Matheu, M. P.; Sanna, M. G.; Wang, S. K.; Jo, E.; Wong, C. H.; Parker, I.; Cahalan, M. D. Sphingosine 1- phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol., 2005, 6(12), 1228-1235.
91. Sanna, M. G.; Wang, S. K.; Gonzalez-Cabrera, P. J.; Don, A.; Marsolais, D.; Matheu, M. P.; Wei, S. H.; Parker, I.; Jo, E.; Cheng, W. C.; Cahalan, M. D.; Wong, C. H.; Rosen, H. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat. Chem. Biol., 2006, 2(8), 434-441.